Evan Douglas Godshall Net Worth & Insider Trades

Evan Douglas Godshall Eyepoint Pharmaceuticals, Inc

As of June 23, 2021

What is Evan Douglas Godshall's Net Worth?

The current estimated net worth of Eyepoint Pharmaceuticals, Inc's Evan Douglas Godshall is estimated to be about $112.42M . Evan Douglas Godshall owns about 29,500 units of Eyepoint Pharmaceuticals, Inc common stock. In the last 3 years at Eyepoint Pharmaceuticals, Inc, Evan Douglas Godshall has sold an estimated value of $0 worth.

What is Evan Douglas Godshall's Past Insider Trading?

Evan Douglas Godshall's largest purchase order was 17,000 units , worth over $29.78K on April 1, 2019. In total, Evan Douglas Godshall has made about 8 transactions over 3 years of their time at Eyepoint Pharmaceuticals, Inc. Evan Douglas Godshall usually trades in June, with the busiest year in 2019.

Evan Douglas Godshall

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Evan Douglas Godshall's Salary in 2020?

As an executive member of Eyepoint Pharmaceuticals, Inc, Evan Douglas Godshall has a total base salary of $545,833 . Evan Douglas Godshall received compensation valued at about $4,551,736 in 2020. The vast majority of their compensation came in the form of stock awards of $3,579,342 , other compensation of $4,161 .

What is Evan Douglas Godshall's' Mailing Address?

  • Mailing address is Suite 4 Level 46 2 Park Street Sidney C3 2000 Australia

Eyepoint Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nancy Lurker 2020 $581,957 - $482,460 $563,216 $454,508 $15,660 $2,097,801
Nancy Lurker 2019 $577,037 - $650,207 $693,165 $144,034 $15,340 $2,079,783
George Elston 2020 $440,000 - - $83,104 $236,940 $15,660 $775,704
George Elston 2019 $58,385 $20,000 - $635,555 - $2,068 $716,008
Dario Paggiarino 2020 $436,156 - $158,864 $185,417 $242,371 $15,660 $1,038,468
Dario Paggiarino 2019 $420,862 - - $275,775 $105,188 $15,340 $817,165
Scott Jones 2020 $376,250 - $158,864 $185,417 $212,135 $15,660 $948,326
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm

What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?

Eyepoint Pharmaceuticals, Inc's most recent insider trade came on March 15, 2022 by Craig Michael Pine who bought 1,000 units worth $12.21K . In the last 4 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $473.18K and bought an estimated value of $22.04M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Nancy Lurker, President & CEO,  Dario Paggiarino, Chief Medical Officer,  and Jay Duker, Chief Operating Officer .

EyePoint Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1